Pharmacokinetics, Volume 25Hans Schönfeld |
From inside the book
Results 1-3 of 59
Page 89
... Serum peak μg / ml Serum half - life h Bioavail- ability % Urinary recovery % of dose Mec . i.m. 273 4.7 ± 0.5 1.0 ± 0.2 335 7.7 ± 0.8 61 ± 2 Mec . i.v. 200 9 0.8 ± 0.2 335 40 ± 2 56 ± 3 Piv . p.o. 400 2.4 ± 0.2 0.9 ± 0.1 25 ± 2 400 2.5 ...
... Serum peak μg / ml Serum half - life h Bioavail- ability % Urinary recovery % of dose Mec . i.m. 273 4.7 ± 0.5 1.0 ± 0.2 335 7.7 ± 0.8 61 ± 2 Mec . i.v. 200 9 0.8 ± 0.2 335 40 ± 2 56 ± 3 Piv . p.o. 400 2.4 ± 0.2 0.9 ± 0.1 25 ± 2 400 2.5 ...
Page 149
... peak [ 105 ] . Repeated administration of 1 - gram doses every 6 h produces a steady elevation of consecutive peaks ... serum peak onset ( newborns - 3 h ; infants under 6 months of age - 2 h [ 82 , 83 ] ) and for lower peaks [ 49 ] ...
... peak [ 105 ] . Repeated administration of 1 - gram doses every 6 h produces a steady elevation of consecutive peaks ... serum peak onset ( newborns - 3 h ; infants under 6 months of age - 2 h [ 82 , 83 ] ) and for lower peaks [ 49 ] ...
Page 171
... serum peak was found for Amikacin [ 18 ] in severely uraemic patients . This peak ( 20 μg · ml - 1 in normal healthy subjects ) reached 30 μg m - 1 in uraemic patients with endogenous creatinine clearance lower than 5 ml min - 1 ( fig ...
... serum peak was found for Amikacin [ 18 ] in severely uraemic patients . This peak ( 20 μg · ml - 1 in normal healthy subjects ) reached 30 μg m - 1 in uraemic patients with endogenous creatinine clearance lower than 5 ml min - 1 ( fig ...
Contents
Penicillins | 3 |
Methods of Determination | 17 |
Synergism | 30 |
Copyright | |
30 other sections not shown
Common terms and phrases
absorption acid Agents Chemother Amikacin aminoglycosides amoxycillin amphotericin ampicillin antibiotics antifungal Antimicrob aqueous Azidocillin bacampicillin benzylpenicillin BERGAN bile biliary bioavailability blood levels carbenicillin cefazolin cephaloridine cephalosporin cephalothin cephradine Chemical Chemotherapy cillin Clin Clindamycin clinical cloxacillin compounds creatinine clearance distribution dosage drug effect erythromycin Flucloxacillin fluid Gentamicin griseofulvin hydrochloride i.m. administration infect infusion intramuscular intravenous isoniazid kidney KUNIN Lincomycin Mean serum mecillinam metabolism metabolites Methicillin mg/kg miconazole ml/min Nafcillin nitrofurantoin oral administration oral dose Oxacillin parenteral patients peak serum PELS penicillin pharm Pharmac Pharmacokinetics Pharmacol pharmacology phenethicillin phenoxymethylpenicillin pivampicillin plasma concentration plasma levels polyenes probenecid protein binding renal clearance renal failure renal function rifampicin ROLINSON and SUTHERLAND salt serum concentrations serum half-life serum levels serum peak serum proteins sodium soluble stearate studies Sulphonamides suppl Table tablets tetracycline therapeutic therapy tion tissue trimethoprim urinary recovery urine vitro vivo warfarin µg/ml